Accelerating the Future of Cell & Gene Therapy

At CytoNiche, we specialize in simplifying the complex world of CGT, especially mesenchymal stem/stromal cells (MSCs) to drive the success of therapeutic commercialization. Our solutions empower you to scale up production with cost-effective, high-quality cells, so that you can focus on what you do best —— developing transformative therapeutics. By optimizing access and affordability, we accelerate the timeline for bringing groundbreaking products to market.

See What Powers Us >

Events & News

More Events&News >

Jan 22,2026

The Industrial Engine for NK Cell Therapy: Scaling NK Cell Therapy with 3D FloTrix™ NK Serum-Free Medium Kit (RNK59)

Unveiling the 3D FloTrix™ NK Serum Free Medium Kit, a serum-free, animal-origin-free, and antibiotic-free medium for scalable, GMP-ready NK cell manufacturing.

Jan 05,2026

World Health Expo (WHX) Labs Dubai

February 10-13, 2026 | World Trade Centre, Dubai

Dec 23,2025

Adipose-Derived Stem Cell Microtissues Achieve Enhanced Cartilage Regeneration Using 3D dECM Microcarriers

ADSC microtissues generated in a 3D dECM microcarrier system exhibit improved paracrine activity and functional cartilage regeneration in vivo.